Paul McCreadie

Paul McCreadie is the current Director at Allay Therapeutics. Prior to this, they served as a Board Member for Rethink First from January 2014 to December 2020, Adavium Medical, ArborMetrix from January 2011 to December 2018, Delphinus Medical Technologies, Inc., and Wellfount Corporation from January 2011 to December 2019. Paul also served as the Chief Operating Officer for CerviLenz, Inc. from January 2009 to December 2010.

Paul McCreadie attended the University of Michigan for both their undergraduate and graduate studies. Paul received a Bachelor of Science in Mechanical Engineering and then went on to earn their Master of Business Administration from the university's Stephen M. Ross School of Business.